Gemcitabine elaidate, is a lipophilic, unsaturated fatty acid ester derivative of gemcitabine (dFdC), an antimetabolite deoxynucleoside analogue, with potential antineoplastic activity. Upon hydrolysis intracellularly by esterases, the prodrug gemcitabine is converted into the active metabolites difluorodeoxycytidine di- and tri-phosphate (dFdCDP and dFdCTP) by deoxycytidine kinase. dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis; dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 2-3 weeks | $ 102 | |
4 mg | 2-3 weeks | $ 193 | |
8 mg | 2-3 weeks | $ 274 | |
20 mg | 2-3 weeks | $ 575 | |
40 mg | 2-3 weeks | $ 891 |
Description | Gemcitabine elaidate, is a lipophilic, unsaturated fatty acid ester derivative of gemcitabine (dFdC), an antimetabolite deoxynucleoside analogue, with potential antineoplastic activity. Upon hydrolysis intracellularly by esterases, the prodrug gemcitabine is converted into the active metabolites difluorodeoxycytidine di- and tri-phosphate (dFdCDP and dFdCTP) by deoxycytidine kinase. dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis; dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis. |
Synonyms | CO-101, Gemcitabine (elaidate), CP-4126, Gemcitabine 5'-elaidate |
CAS No. | 210829-30-4 |
Chemical Formula | C27H43F2N3O5 |
Molecular Weight | 527.654 |
Solubility | DMSO: 26 mg/mL (49.28 mM) |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom